LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes.

doi:10.1038/bjc.1990.372

Back to search

Article

LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes.

British journal of cancer - 1 Nov 1990

Ferrarini M, Ferrero E, Fortis C, Poggi A, Zocchi M R

Abstract excerpt

Both lymphokine activated killer (LAK) cells and specific cytotoxic T lymphocytes appear to play a role in tumour immunity. Tumour infiltrating lymphocytes (TIL) which display a CD56+ phenotype (both CD3+ and CD3-) are also likely to possess anti-tumour activity. We have previously described a 12...

Topics

Antigens, Differentiation, T-Lymphocyte
Antigens, Surface
CD3 Complex
CD56 Antigen
Humans
Killer Cells, Lymphokine-Activated
Lymphocytes, Tumor-Infiltrating
Neoplasms
Phenotype
Receptors, Antigen, T-Cell
T-Lymphocyte Subsets

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.